We are live on
!
Find out more
FBC
Fairfield, Bush & Co Portfolio holdings
AUM
$180M
1-Year Est. Return
39.51%
This Fund
S&P 500
This Quarter
Est. Return
+12.7%
1 Year Est. Return
+39.51%
3 Year Est. Return
+100.99%
5 Year Est. Return
+139.5%
10 Year Est. Return
+536.52%
AUM
$363M
AUM Growth
+$79.3M
(+28%)
Cap. Flow
+$47M
Cap. Flow
% of AUM
12.93%
Top 10 Holdings %
Top 10 Hldgs %
44.65%
Holding
564
New
419
Increased
72
Reduced
36
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.97M |
| 2 |
Apple
AAPL
|
+$6.93M |
| 3 |
Amazon
AMZN
|
+$4.54M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.29M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$2.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$3.76M |
| 2 |
Broadcom
AVGO
|
+$460K |
| 3 |
PepsiCo
PEP
|
+$158K |
| 4 |
TSMC
TSM
|
+$133K |
| 5 |
SoFi Technologies
SOFI
|
+$124K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.73% |
| 2 | Healthcare | 16.53% |
| 3 | Consumer Discretionary | 10.12% |
| 4 | Consumer Staples | 9.89% |
| 5 | Industrials | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
MiMedx Group
MDXG
$602M
| $50.6K | 0.01% |
+7,652
| New | +$39K |
|
227
W.W. Grainger
GWW
$65.3B
| $46.5K | 0.01% |
+59
| New | +$40.6K |
|
228
iShares National Muni Bond ETF
MUB
$45.1B
| $45.4K | 0.01% |
+425
| New | +$45.4K |
|
229
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
| $44.9K | 0.01% |
+338
| New | +$44.6K |
|
230
Martin Marietta Materials
MLM
$31.5B
| $43.9K | 0.01% |
+95
| New | +$37.5K |
|
231
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $40.2K | 0.01% |
+535
| New | +$39.9K |
|
232
Weyerhaeuser
WY
$18B
| $39.5K | 0.01% |
+1,180
| New | +$35.5K |
|
233
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.6B
| $37.5K | 0.01% |
+442
| New | +$33.8K |
|
234
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.07B
| $36.8K | 0.01% |
+400
| New | +$36.6K |
|
235
Zoetis
ZTS
$32.4B
| $36.2K | 0.01% |
+210
| New | +$36.3K |
|
236
Kohl's
KSS
$2.17B
| $35.5K | 0.01% |
+1,540
| New | +$33.3K |
|
237
Prologis
PLD
$135B
| $35.1K | 0.01% |
+286
| New | +$35.2K |
|
238
Corteva
CTVA
$52.6B
| $33.4K | 0.01% |
+583
| New | +$34K |
|
239
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.6B
| $32.7K | 0.01% |
+600
| New | +$31K |
|
240
Alibaba
BABA
$293B
| $32.5K | 0.01% |
+390
| New | +$34.1K |
|
241
Medtronic
MDT
$109B
| $32.3K | 0.01% |
+367
| New | +$31.6K |
|
242
Alcon
ALC
$33.6B
| $31.9K | 0.01% |
+389
| New | +$29.7K |
|
243
Box
BOX
$4.37B
| $29.4K | 0.01% |
+1,000
| New | +$27.7K |
|
|
B
244
Barrick Mining
B
$61.5B
| $28.8K | 0.01% |
+1,700
| New | +$31K |
|
245
USCF Midstream Energy Income Fund
UMI
$509M
| $28.7K | 0.01% |
+837
| New | +$27.9K |
|
246
Ford
F
$58.5B
| $28.7K | 0.01% |
+1,894
| New | +$24K |
|
247
Cigna
CI
$73.7B
| $28.1K | 0.01% |
+100
| New | +$26K |
|
248
Home Depot
HD
$331B
| $28K | 0.01% |
+90
| New | +$26.6K |
|
249
Kyndryl
KD
$2.99B
| $27.7K | 0.01% |
+2,085
| New | +$28.2K |
|
250
GSK
GSK
$104B
| $27.6K | 0.01% |
+773
| New | +$27.7K |
|
Similar funds
KCM
AG
AIC
PCA
HIC
V
RVM
FFA
Fairfield, Bush & Co's Q2 2023 Portfolio in Review
As of Q2 2023, Fairfield, Bush & Co held 564 positions worth $363M, up 28% from $284M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Fairfield, Bush & Co deployed $47M of net new capital in Q2 2023, opening 419 new positions and adding to 72 existing holdings. Its largest new stake was Meta Platforms (Facebook): 5,467 shares worth $1.57M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Novo Nordisk, an estimated $3.76M trimmed.
- Fairfield, Bush & Co's largest Q2 2023 buy was Meta Platforms (Facebook): 5,467 shares worth $1.57M.
- Fairfield, Bush & Co added most to NVIDIA in Q2 2023, an estimated $7.97M increase.
- Fairfield, Bush & Co's biggest Q2 2023 reduction was Novo Nordisk, cutting an estimated $3.76M.
- Fairfield, Bush & Co fully exited SoFi Technologies in Q2 2023, selling an estimated $124K.
- Fairfield, Bush & Co's ten largest holdings make up 45% of its $363M portfolio in Q2 2023.
- Fairfield, Bush & Co opened 419 new positions and closed 1 in Q2 2023.
- Fairfield, Bush & Co's portfolio value rose 28% quarter-over-quarter to $363M.
Based on Fairfield, Bush & Co's 13F filing for Q2 2023, filed 15 Aug 2023.